New Article Uncovering Behavioral Science’s Role in Successful Obesity Trials Published inClinical Trial Vanguard
As the global obesity drug market accelerates toward an estimated $200 billion valuation, sponsors face more than just…
News
News
News
Cognivia Poster Reveals 35% Precision Gain in Acute Pain RCTs Using Placebell Covariates
At the United States Association for the Study of Pain 2025 conference, Cognivia presented compelling new data from…
News
New Evidence for Placebell and Compl-AI in Type 1 Diabetes
At the recent 2025 Advanced Technologies & Treatments for Diabetes congress in Amsterdam, Cognivia presented two new scientific posters demonstrating…
Insights
Discussion on the Use of Placebell and FDA’s Feedback
Cognivia recently initiated a discussion with the FDA through the “Innovative Science and Technology Approaches for New Drugs…
Events
Cognivia to Host Webinar on FDA’s Draft Guidance for Diversity in Clinical Trials
Cognivia is pleased to announce an upcoming webinar focused on strategies for aligning with the FDA’s recent draft…
News
Cognivia Predictive Algorithm for More Personalized Neuropathic Pain Treatment
Alternative and safe therapeutic approaches for neuropathic pain are needed. Interdisciplinary and collaborative research is essential to advance…